Hemostats Market By Type (Thrombin Based Hemostats, Oxidized Regenerated Cellulose Based Hemostats, Combination Hemostats, Gelatin Based Hemostats, Collagen Based Hemostats, Others), By Formulation (Matrix and Gel Hemostats, Sheet and Pad Hemostats, Sponge Hemostats, Powder Hemostats, Others), By Application (Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Hemostats are materials or products that when placed on a bleeding site during surgery stop the bleeding by the bloods clotting function. Hemostat are used in many surgical procedures to control bleeding on tissue or organ. They stop both internal and external major or minor bleeding due to injuries, cuts, tearing, ruptures, dental operations, and surgical or spontaneous interventions. Different types of hemostats are available in the market such as thrombin-based hemostats, collagen-based hemostats, gelatin-based hemostats, and cellulose-based hemostats. Hemostats are designed to clamp small blood vessels for hemorrhage control. As a result, they are widely employed in surgical centers, hospitals, and nursing positions. They are available in various sizes, materials, and compositions and used in surgeries and trauma cases. 

The major factors that foster the growth of the global hemostats market are surge in number of surgical procedures and availability of medical specialties for the treatment and management of several diseases. In addition, rise in number of cardiac surgeries & orthopedic surgeries and surge in number of injuries and accidents boost the growth of the hemostats market. Moreover, technologically advancements in products having rapid effects are expected to propel the demand for hemostats during the forecast period.

For instance, in February 2021, EndoClot Plus Inc. announced that it received an FDA approval for EndoClot Polysaccharide Hemostatic System. This innovative product helps gastroenterologists to prevent bleeding rapidly. This technology represents a significant milestone in advancing the care of gastrointestinal problems. In addition, in March 2020, the Institute of Nano Science and Technology, under the Department of Science & Technology, developed a starch-based hemostat material. This material helps in stopping the blood flow by concentrating the natural clotting factors in the blood. Thus, the aforementioned factors are anticipated to drive the growth of the hemostat market.

As per the estimates published by the National Center for Biotechnology Information (NCBI), about 60–70% of all transfused red blood cells are utilized in a surgical setting, as bleeding during surgeries is one the most feared complications to occur in these procedures and hemostats reduce that complications of bleeding during surgical procedure. This has led to substantial demand for hemostat product offerings in the global market.

However, clinical limitations with certain products severely hamper the growth of the market. In contrast, increase in number of number of hospitals and surgical centers in both developed and emerging countries is  expected to offer lucrative growth opportunities for players in the hemostats market.

The global hemostats market is segmented into type, formulation, application, and region to provide a detailed assessment of the market. By type, the market is segregated into thrombin-based hemostats, oxidized regenerated cellulose-based hemostats, combination hemostats, gelation-based hemostats, collagen-based hemostats, and others. On the basis of formulation, it is categorized into matrix & gel hemostats, sheet & pad hemostats, sponge hemostats, powder hemostats, and others. Depending on application, it is fragmented into orthopedic surgery, general surgery, neurological surgery, cardiovascular surgery, reconstructive surgery, gynecological surgery, and other surgeries. 

Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global hemostats market are Baxter International Inc., B. Braun Melsungen AG, Becton Dickinson and Company, Hemostatis LLC, Integra Life Sciences Corporation, Johnson & Johnson, Medtronic Plc, Pfizer Inc., Stryker Corporation, and Teleflex Incorporated.

 

By Type

● Thrombin Based Hemostats

● Oxidized Regenerated Cellulose Based Hemostats

● Combination Hemostats

● Gelatin Based Hemostats

● Collagen Based Hemostats

● Others

By Formulation

● Sheet and Pad Hemostats

● Sponge Hemostats

● Powder Hemostats

● Others

● Matrix and Gel Hemostats

By Application

● Orthopedic Surgery

● General Surgery

● Neurological Surgery

● Cardiovascular Surgery

● Reconstructive Surgery

● Gynecological Surgery

● Others

By Region

● North America

○ U.S.

○ Canada

○ Mexico

● Europe

○ Germany

○ France

○ U.K.

○ Italy

○ Spain

○ Rest of Europe

● Asia-Pacific

○ Japan

○ China

○ India

○ Australia

○ South Korea

○ Rest of Asia-Pacific

● LAMEA

○ Brazil

○ Saudi Arabia

○ South Africa

○ Rest of LAMEA

● Key Market Players

○ Baxter International Inc.

○ B.Braun Melsungen AG

○ Becton Dickinson and Company

○ Hemostatis LLC

○ Integra Life Sciences Holding Corporation

○ Johnson and Johnson

○ Medtronic Plc

○ Pfizer Inc.

○ Stryker Corporation

○ Teleflex Incorporate

1.1.Report description

1.2.Key market segments

1.3.Key benefits to the stakeholders

1.4.Research Methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

2.1.Key findings of the study

2.2.CXO Perspective

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis

3.4.Top player positioning

3.5.Market dynamics

3.5.1.Drivers

3.5.2.Restraints

3.5.3.Opportunities

3.6.COVID-19 Impact Analysis on the market

4.1 Overview

4.1.1 Market size and forecast

4.2 Thrombin Based Hemostats

4.2.1 Key market trends, growth factors and opportunities

4.2.2 Market size and forecast, by region

4.2.3 Market analysis by country

4.3 Oxidized Regenerated Cellulose Based Hemostats

4.3.1 Key market trends, growth factors and opportunities

4.3.2 Market size and forecast, by region

4.3.3 Market analysis by country

4.4 Combination Hemostats

4.4.1 Key market trends, growth factors and opportunities

4.4.2 Market size and forecast, by region

4.4.3 Market analysis by country

4.5 Gelatin Based Hemostats

4.5.1 Key market trends, growth factors and opportunities

4.5.2 Market size and forecast, by region

4.5.3 Market analysis by country

4.6 Collagen Based Hemostats

4.6.1 Key market trends, growth factors and opportunities

4.6.2 Market size and forecast, by region

4.6.3 Market analysis by country

4.7 Others

4.7.1 Key market trends, growth factors and opportunities

4.7.2 Market size and forecast, by region

4.7.3 Market analysis by country

5.1 Overview

5.1.1 Market size and forecast

5.2 Matrix and Gel Hemostats

5.2.1 Key market trends, growth factors and opportunities

5.2.2 Market size and forecast, by region

5.2.3 Market analysis by country

5.3 Sheet and Pad Hemostats

5.3.1 Key market trends, growth factors and opportunities

5.3.2 Market size and forecast, by region

5.3.3 Market analysis by country

5.4 Sponge Hemostats

5.4.1 Key market trends, growth factors and opportunities

5.4.2 Market size and forecast, by region

5.4.3 Market analysis by country

5.5 Powder Hemostats

5.5.1 Key market trends, growth factors and opportunities

5.5.2 Market size and forecast, by region

5.5.3 Market analysis by country

5.6 Others

5.6.1 Key market trends, growth factors and opportunities

5.6.2 Market size and forecast, by region

5.6.3 Market analysis by country

6.1 Overview

6.1.1 Market size and forecast

6.2 Orthopedic Surgery

6.2.1 Key market trends, growth factors and opportunities

6.2.2 Market size and forecast, by region

6.2.3 Market analysis by country

6.3 General Surgery

6.3.1 Key market trends, growth factors and opportunities

6.3.2 Market size and forecast, by region

6.3.3 Market analysis by country

6.4 Neurological Surgery

6.4.1 Key market trends, growth factors and opportunities

6.4.2 Market size and forecast, by region

6.4.3 Market analysis by country

6.5 Cardiovascular Surgery

6.5.1 Key market trends, growth factors and opportunities

6.5.2 Market size and forecast, by region

6.5.3 Market analysis by country

6.6 Reconstructive Surgery

6.6.1 Key market trends, growth factors and opportunities

6.6.2 Market size and forecast, by region

6.6.3 Market analysis by country

6.7 Gynecological Surgery

6.7.1 Key market trends, growth factors and opportunities

6.7.2 Market size and forecast, by region

6.7.3 Market analysis by country

6.8 Others

6.8.1 Key market trends, growth factors and opportunities

6.8.2 Market size and forecast, by region

6.8.3 Market analysis by country

7.1 Overview

7.1.1 Market size and forecast

7.2 North America

7.2.1 Key trends and opportunities

7.2.2 North America Market size and forecast, by Type

7.2.3 North America Market size and forecast, by Formulation

7.2.4 North America Market size and forecast, by Application

7.2.5 North America Market size and forecast, by country

7.2.5.1 U.S.

7.2.5.1.1 Market size and forecast, by Type

7.2.5.1.2 Market size and forecast, by Formulation

7.2.5.1.3 Market size and forecast, by Application

7.2.5.2 Canada

7.2.5.2.1 Market size and forecast, by Type

7.2.5.2.2 Market size and forecast, by Formulation

7.2.5.2.3 Market size and forecast, by Application

7.2.5.3 Mexico

7.2.5.3.1 Market size and forecast, by Type

7.2.5.3.2 Market size and forecast, by Formulation

7.2.5.3.3 Market size and forecast, by Application

7.3 Europe

7.3.1 Key trends and opportunities

7.3.2 Europe Market size and forecast, by Type

7.3.3 Europe Market size and forecast, by Formulation

7.3.4 Europe Market size and forecast, by Application

7.3.5 Europe Market size and forecast, by country

7.3.5.1 Germany

7.3.5.1.1 Market size and forecast, by Type

7.3.5.1.2 Market size and forecast, by Formulation

7.3.5.1.3 Market size and forecast, by Application

7.3.5.2 France

7.3.5.2.1 Market size and forecast, by Type

7.3.5.2.2 Market size and forecast, by Formulation

7.3.5.2.3 Market size and forecast, by Application

7.3.5.3 U.K.

7.3.5.3.1 Market size and forecast, by Type

7.3.5.3.2 Market size and forecast, by Formulation

7.3.5.3.3 Market size and forecast, by Application

7.3.5.4 Italy

7.3.5.4.1 Market size and forecast, by Type

7.3.5.4.2 Market size and forecast, by Formulation

7.3.5.4.3 Market size and forecast, by Application

7.3.5.5 Spain

7.3.5.5.1 Market size and forecast, by Type

7.3.5.5.2 Market size and forecast, by Formulation

7.3.5.5.3 Market size and forecast, by Application

7.3.5.6 Rest of Europe

7.3.5.6.1 Market size and forecast, by Type

7.3.5.6.2 Market size and forecast, by Formulation

7.3.5.6.3 Market size and forecast, by Application

7.4 Asia-Pacific

7.4.1 Key trends and opportunities

7.4.2 Asia-Pacific Market size and forecast, by Type

7.4.3 Asia-Pacific Market size and forecast, by Formulation

7.4.4 Asia-Pacific Market size and forecast, by Application

7.4.5 Asia-Pacific Market size and forecast, by country

7.4.5.1 Japan

7.4.5.1.1 Market size and forecast, by Type

7.4.5.1.2 Market size and forecast, by Formulation

7.4.5.1.3 Market size and forecast, by Application

7.4.5.2 China

7.4.5.2.1 Market size and forecast, by Type

7.4.5.2.2 Market size and forecast, by Formulation

7.4.5.2.3 Market size and forecast, by Application

7.4.5.3 India

7.4.5.3.1 Market size and forecast, by Type

7.4.5.3.2 Market size and forecast, by Formulation

7.4.5.3.3 Market size and forecast, by Application

7.4.5.4 Australia

7.4.5.4.1 Market size and forecast, by Type

7.4.5.4.2 Market size and forecast, by Formulation

7.4.5.4.3 Market size and forecast, by Application

7.4.5.5 South Korea

7.4.5.5.1 Market size and forecast, by Type

7.4.5.5.2 Market size and forecast, by Formulation

7.4.5.5.3 Market size and forecast, by Application

7.4.5.6 Rest of Asia-Pacific

7.4.5.6.1 Market size and forecast, by Type

7.4.5.6.2 Market size and forecast, by Formulation

7.4.5.6.3 Market size and forecast, by Application

7.5 LAMEA

7.5.1 Key trends and opportunities

7.5.2 LAMEA Market size and forecast, by Type

7.5.3 LAMEA Market size and forecast, by Formulation

7.5.4 LAMEA Market size and forecast, by Application

7.5.5 LAMEA Market size and forecast, by country

7.5.5.1 Brazil

7.5.5.1.1 Market size and forecast, by Type

7.5.5.1.2 Market size and forecast, by Formulation

7.5.5.1.3 Market size and forecast, by Application

7.5.5.2 Saudi Arabia

7.5.5.2.1 Market size and forecast, by Type

7.5.5.2.2 Market size and forecast, by Formulation

7.5.5.2.3 Market size and forecast, by Application

7.5.5.3 South Africa

7.5.5.3.1 Market size and forecast, by Type

7.5.5.3.2 Market size and forecast, by Formulation

7.5.5.3.3 Market size and forecast, by Application

7.5.5.4 Rest of LAMEA

7.5.5.4.1 Market size and forecast, by Type

7.5.5.4.2 Market size and forecast, by Formulation

7.5.5.4.3 Market size and forecast, by Application

8.1. Introduction

8.2. Top winning strategies

8.3. Product Mapping of Top 10 Player

8.4. Competitive Dashboard

8.5. Competitive Heatmap

8.6. Key developments

9.1 Baxter International Inc.

9.1.1 Company overview

9.1.2 Company snapshot

9.1.3 Operating business segments

9.1.4 Product portfolio

9.1.5 Business performance

9.1.6 Key strategic moves and developments

9.2 B.Braun Melsungen AG

9.2.1 Company overview

9.2.2 Company snapshot

9.2.3 Operating business segments

9.2.4 Product portfolio

9.2.5 Business performance

9.2.6 Key strategic moves and developments

9.3 Becton Dickinson and Company

9.3.1 Company overview

9.3.2 Company snapshot

9.3.3 Operating business segments

9.3.4 Product portfolio

9.3.5 Business performance

9.3.6 Key strategic moves and developments

9.4 Hemostatis LLC

9.4.1 Company overview

9.4.2 Company snapshot

9.4.3 Operating business segments

9.4.4 Product portfolio

9.4.5 Business performance

9.4.6 Key strategic moves and developments

9.5 Integra Life Sciences Holding Corporation

9.5.1 Company overview

9.5.2 Company snapshot

9.5.3 Operating business segments

9.5.4 Product portfolio

9.5.5 Business performance

9.5.6 Key strategic moves and developments

9.6 Johnson and Johnson

9.6.1 Company overview

9.6.2 Company snapshot

9.6.3 Operating business segments

9.6.4 Product portfolio

9.6.5 Business performance

9.6.6 Key strategic moves and developments

9.7 Medtronic Plc

9.7.1 Company overview

9.7.2 Company snapshot

9.7.3 Operating business segments

9.7.4 Product portfolio

9.7.5 Business performance

9.7.6 Key strategic moves and developments

9.8 Pfizer Inc.

9.8.1 Company overview

9.8.2 Company snapshot

9.8.3 Operating business segments

9.8.4 Product portfolio

9.8.5 Business performance

9.8.6 Key strategic moves and developments

9.9 Stryker Corporation

9.9.1 Company overview

9.9.2 Company snapshot

9.9.3 Operating business segments

9.9.4 Product portfolio

9.9.5 Business performance

9.9.6 Key strategic moves and developments

9.10 Teleflex Incorporated

9.10.1 Company overview

9.10.2 Company snapshot

9.10.3 Operating business segments

9.10.4 Product portfolio

9.10.5 Business performance

9.10.6 Key strategic moves and development

LIST OF TABLES

TABLE 1. GLOBAL HEMOSTATS MARKET, BY TYPE, 2021-2031,($MILLION)

TABLE 2. HEMOSTATS MARKET REVENUE, FOR THROMBIN BASED HEMOSTATS, BY REGION , 2021-2031,($MILLION)

TABLE 3. HEMOSTATS MARKET FOR THROMBIN BASED HEMOSTATS BY COUNTRY, 2021-2031,($MILLION)

TABLE 4. HEMOSTATS MARKET REVENUE, FOR OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS, BY REGION , 2021-2031,($MILLION)

TABLE 5. HEMOSTATS MARKET FOR OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS BY COUNTRY, 2021-2031,($MILLION)

TABLE 6. HEMOSTATS MARKET REVENUE, FOR COMBINATION HEMOSTATS, BY REGION , 2021-2031,($MILLION)

TABLE 7. HEMOSTATS MARKET FOR COMBINATION HEMOSTATS BY COUNTRY, 2021-2031,($MILLION)

TABLE 8. HEMOSTATS MARKET REVENUE, FOR GELATIN BASED HEMOSTATS, BY REGION , 2021-2031,($MILLION)

TABLE 9. HEMOSTATS MARKET FOR GELATIN BASED HEMOSTATS BY COUNTRY, 2021-2031,($MILLION)

TABLE 10. HEMOSTATS MARKET REVENUE, FOR COLLAGEN BASED HEMOSTATS, BY REGION , 2021-2031,($MILLION)

TABLE 11. HEMOSTATS MARKET FOR COLLAGEN BASED HEMOSTATS BY COUNTRY, 2021-2031,($MILLION)

TABLE 12. HEMOSTATS MARKET REVENUE, FOR OTHERS, BY REGION , 2021-2031,($MILLION)

TABLE 13. HEMOSTATS MARKET FOR OTHERS BY COUNTRY, 2021-2031,($MILLION)

TABLE 14. GLOBAL HEMOSTATS MARKET, BY FORMULATION, 2021-2031,($MILLION)

TABLE 15. HEMOSTATS MARKET REVENUE, FOR MATRIX AND GEL HEMOSTATS, BY REGION , 2021-2031,($MILLION)

TABLE 16. HEMOSTATS MARKET FOR MATRIX AND GEL HEMOSTATS BY COUNTRY, 2021-2031,($MILLION)

TABLE 17. HEMOSTATS MARKET REVENUE, FOR SHEET AND PAD HEMOSTATS, BY REGION , 2021-2031,($MILLION)

TABLE 18. HEMOSTATS MARKET FOR SHEET AND PAD HEMOSTATS BY COUNTRY, 2021-2031,($MILLION)

TABLE 19. HEMOSTATS MARKET REVENUE, FOR SPONGE HEMOSTATS, BY REGION , 2021-2031,($MILLION)

TABLE 20. HEMOSTATS MARKET FOR SPONGE HEMOSTATS BY COUNTRY, 2021-2031,($MILLION)

TABLE 21. HEMOSTATS MARKET REVENUE, FOR POWDER HEMOSTATS, BY REGION , 2021-2031,($MILLION)

TABLE 22. HEMOSTATS MARKET FOR POWDER HEMOSTATS BY COUNTRY, 2021-2031,($MILLION)

TABLE 23. HEMOSTATS MARKET REVENUE, FOR OTHERS, BY REGION , 2021-2031,($MILLION)

TABLE 24. HEMOSTATS MARKET FOR OTHERS BY COUNTRY, 2021-2031,($MILLION)

TABLE 25. GLOBAL HEMOSTATS MARKET, BY APPLICATION, 2021-2031,($MILLION)

TABLE 26. HEMOSTATS MARKET REVENUE, FOR ORTHOPEDIC SURGERY, BY REGION , 2021-2031,($MILLION)

TABLE 27. HEMOSTATS MARKET FOR ORTHOPEDIC SURGERY BY COUNTRY, 2021-2031,($MILLION)

TABLE 28. HEMOSTATS MARKET REVENUE, FOR GENERAL SURGERY, BY REGION , 2021-2031,($MILLION)

TABLE 29. HEMOSTATS MARKET FOR GENERAL SURGERY BY COUNTRY, 2021-2031,($MILLION)

TABLE 30. HEMOSTATS MARKET REVENUE, FOR NEUROLOGICAL SURGERY, BY REGION , 2021-2031,($MILLION)

TABLE 31. HEMOSTATS MARKET FOR NEUROLOGICAL SURGERY BY COUNTRY, 2021-2031,($MILLION)

TABLE 32. HEMOSTATS MARKET REVENUE, FOR CARDIOVASCULAR SURGERY, BY REGION , 2021-2031,($MILLION)

TABLE 33. HEMOSTATS MARKET FOR CARDIOVASCULAR SURGERY BY COUNTRY, 2021-2031,($MILLION)

TABLE 34. HEMOSTATS MARKET REVENUE, FOR RECONSTRUCTIVE SURGERY, BY REGION , 2021-2031,($MILLION)

TABLE 35. HEMOSTATS MARKET FOR RECONSTRUCTIVE SURGERY BY COUNTRY, 2021-2031,($MILLION)

TABLE 36. HEMOSTATS MARKET REVENUE, FOR GYNECOLOGICAL SURGERY, BY REGION , 2021-2031,($MILLION)

TABLE 37. HEMOSTATS MARKET FOR GYNECOLOGICAL SURGERY BY COUNTRY, 2021-2031,($MILLION)

TABLE 38. HEMOSTATS MARKET REVENUE, FOR OTHERS, BY REGION , 2021-2031,($MILLION)

TABLE 39. HEMOSTATS MARKET FOR OTHERS BY COUNTRY, 2021-2031,($MILLION)

TABLE 40. HEMOSTATS MARKET, BY REGION, 2021-2031,($MILLION)

TABLE 41. NORTH AMERICA HEMOSTATS MARKET, BY TYPE, 2021-2031,($MILLION)

TABLE 42. NORTH AMERICA HEMOSTATS MARKET, BY FORMULATION, 2021-2031,($MILLION)

TABLE 43. NORTH AMERICA HEMOSTATS MARKET, BY APPLICATION, 2021-2031,($MILLION)

TABLE 44. NORTH AMERICA HEMOSTATS MARKET, BY COUNTRY, 2021-2031,($MILLION)

TABLE 45. U.S. HEMOSTATS MARKET, BY TYPE, 2021-2031,($MILLION)

TABLE 46. U.S. HEMOSTATS MARKET, BY FORMULATION, 2021-2031,($MILLION)

TABLE 47. U.S. HEMOSTATS MARKET, BY APPLICATION, 2021-2031,($MILLION)

TABLE 48. CANADA HEMOSTATS MARKET, BY TYPE, 2021-2031,($MILLION)

TABLE 49. CANADA HEMOSTATS MARKET, BY FORMULATION, 2021-2031,($MILLION)

TABLE 50. CANADA HEMOSTATS MARKET, BY APPLICATION, 2021-2031,($MILLION)

TABLE 51. MEXICO HEMOSTATS MARKET, BY TYPE, 2021-2031,($MILLION)

TABLE 52. MEXICO HEMOSTATS MARKET, BY FORMULATION, 2021-2031,($MILLION)

TABLE 53. MEXICO HEMOSTATS MARKET, BY APPLICATION, 2021-2031,($MILLION)

TABLE 54. EUROPE HEMOSTATS MARKET, BY TYPE, 2021-2031,($MILLION)

TABLE 55. EUROPE HEMOSTATS MARKET, BY FORMULATION, 2021-2031,($MILLION)

TABLE 56. EUROPE HEMOSTATS MARKET, BY APPLICATION, 2021-2031,($MILLION)

TABLE 57. EUROPE HEMOSTATS MARKET, BY COUNTRY, 2021-2031,($MILLION)

TABLE 58. GERMANY HEMOSTATS MARKET, BY TYPE, 2021-2031,($MILLION)

TABLE 59. GERMANY HEMOSTATS MARKET, BY FORMULATION, 2021-2031,($MILLION)

TABLE 60. GERMANY HEMOSTATS MARKET, BY APPLICATION, 2021-2031,($MILLION)

TABLE 61. FRANCE HEMOSTATS MARKET, BY TYPE, 2021-2031,($MILLION)

TABLE 62. FRANCE HEMOSTATS MARKET, BY FORMULATION, 2021-2031,($MILLION)

TABLE 63. FRANCE HEMOSTATS MARKET, BY APPLICATION, 2021-2031,($MILLION)

TABLE 64. U.K. HEMOSTATS MARKET, BY TYPE, 2021-2031,($MILLION)

TABLE 65. U.K. HEMOSTATS MARKET, BY FORMULATION, 2021-2031,($MILLION)

TABLE 66. U.K. HEMOSTATS MARKET, BY APPLICATION, 2021-2031,($MILLION)

TABLE 67. ITALY HEMOSTATS MARKET, BY TYPE, 2021-2031,($MILLION)

TABLE 68. ITALY HEMOSTATS MARKET, BY FORMULATION, 2021-2031,($MILLION)

TABLE 69. ITALY HEMOSTATS MARKET, BY APPLICATION, 2021-2031,($MILLION)

TABLE 70. SPAIN HEMOSTATS MARKET, BY TYPE, 2021-2031,($MILLION)

TABLE 71. SPAIN HEMOSTATS MARKET, BY FORMULATION, 2021-2031,($MILLION)

TABLE 72. SPAIN HEMOSTATS MARKET, BY APPLICATION, 2021-2031,($MILLION)

TABLE 73. REST OF EUROPE HEMOSTATS MARKET, BY TYPE, 2021-2031,($MILLION)

TABLE 74. REST OF EUROPE HEMOSTATS MARKET, BY FORMULATION, 2021-2031,($MILLION)

TABLE 75. REST OF EUROPE HEMOSTATS MARKET, BY APPLICATION, 2021-2031,($MILLION)

TABLE 76. ASIA-PACIFIC HEMOSTATS MARKET, BY TYPE, 2021-2031,($MILLION)

TABLE 77. ASIA-PACIFIC HEMOSTATS MARKET, BY FORMULATION, 2021-2031,($MILLION)

TABLE 78. ASIA-PACIFIC HEMOSTATS MARKET, BY APPLICATION, 2021-2031,($MILLION)

TABLE 79. ASIA-PACIFIC HEMOSTATS MARKET, BY COUNTRY, 2021-2031,($MILLION)

TABLE 80. JAPAN HEMOSTATS MARKET, BY TYPE, 2021-2031,($MILLION)

TABLE 81. JAPAN HEMOSTATS MARKET, BY FORMULATION, 2021-2031,($MILLION)

TABLE 82. JAPAN HEMOSTATS MARKET, BY APPLICATION, 2021-2031,($MILLION)

TABLE 83. CHINA HEMOSTATS MARKET, BY TYPE, 2021-2031,($MILLION)

TABLE 84. CHINA HEMOSTATS MARKET, BY FORMULATION, 2021-2031,($MILLION)

TABLE 85. CHINA HEMOSTATS MARKET, BY APPLICATION, 2021-2031,($MILLION)

TABLE 86. INDIA HEMOSTATS MARKET, BY TYPE, 2021-2031,($MILLION)

TABLE 87. INDIA HEMOSTATS MARKET, BY FORMULATION, 2021-2031,($MILLION)

TABLE 88. INDIA HEMOSTATS MARKET, BY APPLICATION, 2021-2031,($MILLION)

TABLE 89. AUSTRALIA HEMOSTATS MARKET, BY TYPE, 2021-2031,($MILLION)

TABLE 90. AUSTRALIA HEMOSTATS MARKET, BY FORMULATION, 2021-2031,($MILLION)

TABLE 91. AUSTRALIA HEMOSTATS MARKET, BY APPLICATION, 2021-2031,($MILLION)

TABLE 92. SOUTH KOREA HEMOSTATS MARKET, BY TYPE, 2021-2031,($MILLION)

TABLE 93. SOUTH KOREA HEMOSTATS MARKET, BY FORMULATION, 2021-2031,($MILLION)

TABLE 94. SOUTH KOREA HEMOSTATS MARKET, BY APPLICATION, 2021-2031,($MILLION)

TABLE 95. REST OF ASIA-PACIFIC HEMOSTATS MARKET, BY TYPE, 2021-2031,($MILLION)

TABLE 96. REST OF ASIA-PACIFIC HEMOSTATS MARKET, BY FORMULATION, 2021-2031,($MILLION)

TABLE 97. REST OF ASIA-PACIFIC HEMOSTATS MARKET, BY APPLICATION, 2021-2031,($MILLION)

TABLE 98. LAMEA HEMOSTATS MARKET, BY TYPE, 2021-2031,($MILLION)

TABLE 99. LAMEA HEMOSTATS MARKET, BY FORMULATION, 2021-2031,($MILLION)

TABLE 100. LAMEA HEMOSTATS MARKET, BY APPLICATION, 2021-2031,($MILLION)

TABLE 101. LAMEA HEMOSTATS MARKET, BY COUNTRY, 2021-2031,($MILLION)

TABLE 102. BRAZIL HEMOSTATS MARKET, BY TYPE, 2021-2031,($MILLION)

TABLE 103. BRAZIL HEMOSTATS MARKET, BY FORMULATION, 2021-2031,($MILLION)

TABLE 104. BRAZIL HEMOSTATS MARKET, BY APPLICATION, 2021-2031,($MILLION)

TABLE 105. SAUDI ARABIA HEMOSTATS MARKET, BY TYPE, 2021-2031,($MILLION)

TABLE 106. SAUDI ARABIA HEMOSTATS MARKET, BY FORMULATION, 2021-2031,($MILLION)

TABLE 107. SAUDI ARABIA HEMOSTATS MARKET, BY APPLICATION, 2021-2031,($MILLION)

TABLE 108. SOUTH AFRICA HEMOSTATS MARKET, BY TYPE, 2021-2031,($MILLION)

TABLE 109. SOUTH AFRICA HEMOSTATS MARKET, BY FORMULATION, 2021-2031,($MILLION)

TABLE 110. SOUTH AFRICA HEMOSTATS MARKET, BY APPLICATION, 2021-2031,($MILLION)

TABLE 111. REST OF LAMEA HEMOSTATS MARKET, BY TYPE, 2021-2031,($MILLION)

TABLE 112. REST OF LAMEA HEMOSTATS MARKET, BY FORMULATION, 2021-2031,($MILLION)

TABLE 113. REST OF LAMEA HEMOSTATS MARKET, BY APPLICATION, 2021-2031,($MILLION)

TABLE 114.BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT

TABLE 115.BAXTER INTERNATIONAL INC.: OPERATING SEGMENTS

TABLE 116.BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO

TABLE 117.BAXTER INTERNATIONAL INC.: NET SALES,

TABLE 118.BAXTER INTERNATIONAL INC.: KEY STRATERGIES

TABLE 119.B.BRAUN MELSUNGEN AG: COMPANY SNAPSHOT

TABLE 120.B.BRAUN MELSUNGEN AG: OPERATING SEGMENTS

TABLE 121.B.BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO

TABLE 122.B.BRAUN MELSUNGEN AG: NET SALES,

TABLE 123.B.BRAUN MELSUNGEN AG: KEY STRATERGIES

TABLE 124.BECTON DICKINSON AND COMPANY: COMPANY SNAPSHOT

TABLE 125.BECTON DICKINSON AND COMPANY: OPERATING SEGMENTS

TABLE 126.BECTON DICKINSON AND COMPANY: PRODUCT PORTFOLIO

TABLE 127.BECTON DICKINSON AND COMPANY: NET SALES,

TABLE 128.BECTON DICKINSON AND COMPANY: KEY STRATERGIES

TABLE 129.HEMOSTATIS LLC: COMPANY SNAPSHOT

TABLE 130.HEMOSTATIS LLC: OPERATING SEGMENTS

TABLE 131.HEMOSTATIS LLC: PRODUCT PORTFOLIO

TABLE 132.HEMOSTATIS LLC: NET SALES,

TABLE 133.HEMOSTATIS LLC: KEY STRATERGIES

TABLE 134.INTEGRA LIFE SCIENCES HOLDING CORPORATION: COMPANY SNAPSHOT

TABLE 135.INTEGRA LIFE SCIENCES HOLDING CORPORATION: OPERATING SEGMENTS

TABLE 136.INTEGRA LIFE SCIENCES HOLDING CORPORATION: PRODUCT PORTFOLIO

TABLE 137.INTEGRA LIFE SCIENCES HOLDING CORPORATION: NET SALES,

TABLE 138.INTEGRA LIFE SCIENCES HOLDING CORPORATION: KEY STRATERGIES

TABLE 139.JOHNSON AND JOHNSON: COMPANY SNAPSHOT

TABLE 140.JOHNSON AND JOHNSON: OPERATING SEGMENTS

TABLE 141.JOHNSON AND JOHNSON: PRODUCT PORTFOLIO

TABLE 142.JOHNSON AND JOHNSON: NET SALES,

TABLE 143.JOHNSON AND JOHNSON: KEY STRATERGIES

TABLE 144.MEDTRONIC PLC: COMPANY SNAPSHOT

TABLE 145.MEDTRONIC PLC: OPERATING SEGMENTS

TABLE 146.MEDTRONIC PLC: PRODUCT PORTFOLIO

TABLE 147.MEDTRONIC PLC: NET SALES,

TABLE 148.MEDTRONIC PLC: KEY STRATERGIES

TABLE 149.PFIZER INC.: COMPANY SNAPSHOT

TABLE 150.PFIZER INC.: OPERATING SEGMENTS

TABLE 151.PFIZER INC.: PRODUCT PORTFOLIO

TABLE 152.PFIZER INC.: NET SALES,

TABLE 153.PFIZER INC.: KEY STRATERGIES

TABLE 154.STRYKER CORPORATION: COMPANY SNAPSHOT

TABLE 155.STRYKER CORPORATION: OPERATING SEGMENTS

TABLE 156.STRYKER CORPORATION: PRODUCT PORTFOLIO

TABLE 157.STRYKER CORPORATION: NET SALES,

TABLE 158.STRYKER CORPORATION: KEY STRATERGIES

TABLE 159.TELEFLEX INCORPORATED: COMPANY SNAPSHOT

TABLE 160.TELEFLEX INCORPORATED: OPERATING SEGMENTS

TABLE 161.TELEFLEX INCORPORATED: PRODUCT PORTFOLIO

TABLE 162.TELEFLEX INCORPORATED: NET SALES,

TABLE 163.TELEFLEX INCORPORATED: KEY STRATERGIES LIST OF FIGURES

FIGURE 1.HEMOSTATS MARKET SEGMENTATION

FIGURE 2.HEMOSTATS MARKET,2021-2031

FIGURE 3.HEMOSTATS MARKET,2021-2031

FIGURE 4. TOP INVESTMENT POCKETS, BY REGION

FIGURE 5.PORTER FIVE-1

FIGURE 6.PORTER FIVE-2

FIGURE 7.PORTER FIVE-3

FIGURE 8.PORTER FIVE-4

FIGURE 9.PORTER FIVE-5

FIGURE 10.TOP PLAYER POSITIONING

FIGURE 11.HEMOSTATS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 12.HEMOSTATS MARKET,BY TYPE,2021(%)

FIGURE 13.COMPARATIVE SHARE ANALYSIS OF THROMBIN BASED HEMOSTATS HEMOSTATS MARKET,2021-2031(%)

FIGURE 14.COMPARATIVE SHARE ANALYSIS OF OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS HEMOSTATS MARKET,2021-2031(%)

FIGURE 15.COMPARATIVE SHARE ANALYSIS OF COMBINATION HEMOSTATS HEMOSTATS MARKET,2021-2031(%)

FIGURE 16.COMPARATIVE SHARE ANALYSIS OF GELATIN BASED HEMOSTATS HEMOSTATS MARKET,2021-2031(%)

FIGURE 17.COMPARATIVE SHARE ANALYSIS OF COLLAGEN BASED HEMOSTATS HEMOSTATS MARKET,2021-2031(%)

FIGURE 18.COMPARATIVE SHARE ANALYSIS OF OTHERS HEMOSTATS MARKET,2021-2031(%)

FIGURE 19.HEMOSTATS MARKET,BY FORMULATION,2021(%)

FIGURE 20.COMPARATIVE SHARE ANALYSIS OF MATRIX AND GEL HEMOSTATS HEMOSTATS MARKET,2021-2031(%)

FIGURE 21.COMPARATIVE SHARE ANALYSIS OF SHEET AND PAD HEMOSTATS HEMOSTATS MARKET,2021-2031(%)

FIGURE 22.COMPARATIVE SHARE ANALYSIS OF SPONGE HEMOSTATS HEMOSTATS MARKET,2021-2031(%)

FIGURE 23.COMPARATIVE SHARE ANALYSIS OF POWDER HEMOSTATS HEMOSTATS MARKET,2021-2031(%)

FIGURE 24.COMPARATIVE SHARE ANALYSIS OF OTHERS HEMOSTATS MARKET,2021-2031(%)

FIGURE 25.HEMOSTATS MARKET,BY APPLICATION,2021(%)

FIGURE 26.COMPARATIVE SHARE ANALYSIS OF ORTHOPEDIC SURGERY HEMOSTATS MARKET,2021-2031(%)

FIGURE 27.COMPARATIVE SHARE ANALYSIS OF GENERAL SURGERY HEMOSTATS MARKET,2021-2031(%)

FIGURE 28.COMPARATIVE SHARE ANALYSIS OF NEUROLOGICAL SURGERY HEMOSTATS MARKET,2021-2031(%)

FIGURE 29.COMPARATIVE SHARE ANALYSIS OF CARDIOVASCULAR SURGERY HEMOSTATS MARKET,2021-2031(%)

FIGURE 30.COMPARATIVE SHARE ANALYSIS OF RECONSTRUCTIVE SURGERY HEMOSTATS MARKET,2021-2031(%)

FIGURE 31.COMPARATIVE SHARE ANALYSIS OF GYNECOLOGICAL SURGERY HEMOSTATS MARKET,2021-2031(%)

FIGURE 32.COMPARATIVE SHARE ANALYSIS OF OTHERS HEMOSTATS MARKET,2021-2031(%)

FIGURE 33.HEMOSTATS MARKET BY REGION,2021

FIGURE 34.U.S. HEMOSTATS MARKET,2021-2031($MILLION)

FIGURE 35.CANADA HEMOSTATS MARKET,2021-2031($MILLION)

FIGURE 36.MEXICO HEMOSTATS MARKET,2021-2031($MILLION)

FIGURE 37.GERMANY HEMOSTATS MARKET,2021-2031($MILLION)

FIGURE 38.FRANCE HEMOSTATS MARKET,2021-2031($MILLION)

FIGURE 39.U.K. HEMOSTATS MARKET,2021-2031($MILLION)

FIGURE 40.ITALY HEMOSTATS MARKET,2021-2031($MILLION)

FIGURE 41.SPAIN HEMOSTATS MARKET,2021-2031($MILLION)

FIGURE 42.REST OF EUROPE HEMOSTATS MARKET,2021-2031($MILLION)

FIGURE 43.JAPAN HEMOSTATS MARKET,2021-2031($MILLION)

FIGURE 44.CHINA HEMOSTATS MARKET,2021-2031($MILLION)

FIGURE 45.INDIA HEMOSTATS MARKET,2021-2031($MILLION)

FIGURE 46.AUSTRALIA HEMOSTATS MARKET,2021-2031($MILLION)

FIGURE 47.SOUTH KOREA HEMOSTATS MARKET,2021-2031($MILLION)

FIGURE 48.REST OF ASIA-PACIFIC HEMOSTATS MARKET,2021-2031($MILLION)

FIGURE 49.BRAZIL HEMOSTATS MARKET,2021-2031($MILLION)

FIGURE 50.SAUDI ARABIA HEMOSTATS MARKET,2021-2031($MILLION)

FIGURE 51.SOUTH AFRICA HEMOSTATS MARKET,2021-2031($MILLION)

FIGURE 52.REST OF LAMEA HEMOSTATS MARKET,2021-2031($MILLION)

FIGURE 53. TOP WINNING STRATEGIES, BY YEAR

FIGURE 54. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 55. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 56.PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 57.COMPETITIVE DASHBOARD

FIGURE 58.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS

FIGURE 59.BAXTER INTERNATIONAL INC..: NET SALES ,($MILLION)

FIGURE 60.B.BRAUN MELSUNGEN AG.: NET SALES ,($MILLION)

FIGURE 61.BECTON DICKINSON AND COMPANY.: NET SALES ,($MILLION)

FIGURE 62.HEMOSTATIS LLC.: NET SALES ,($MILLION)

FIGURE 63.INTEGRA LIFE SCIENCES HOLDING CORPORATION.: NET SALES ,($MILLION)

FIGURE 64.JOHNSON AND JOHNSON.: NET SALES ,($MILLION)

FIGURE 65.MEDTRONIC PLC.: NET SALES ,($MILLION)

FIGURE 66.PFIZER INC..: NET SALES ,($MILLION)

FIGURE 67.STRYKER CORPORATION.: NET SALES ,($MILLION)

FIGURE 68.TELEFLEX INCORPORATED.: NET SALES ,($MILLION